Advanced Introduction to Pharmaceutical Law (Elgar Advanced Introductions series)

Elgar Advanced Introductions are stimulating and thoughtful introductions to major fields in the social sciences, business and law, expertly written by the world’s leading scholars. Designed to be accessible yet rigorous, they offer concise and lucid surveys of the substantive and policy issues associated with discrete subject areas.

This Advanced Introduction provides a succinct overview of the vital role of pharmaceuticals in protecting and enhancing life and health. Frederick Abbott examines the global network of researchers and industrial companies involved in the developmental process, from fundamental research to testing, manufacturing and distribution. He evaluates the legal frameworks intended to promote the research and development of these essential medicines, including the use of patents, subsidies and other incentives.

Key Features:

• Addresses how the interests of diverse stakeholders are reconciled
• Discusses the use of technology licensing and the impact of AI on pharmaceutical IP
• Identifies the regulatory frameworks that ensure the safety and efficacy of therapeutic medicines and vaccines
• Analyses the broad range of pharmaceutical advertising, promotion and prescription, with a particular focus on the growing role of telemedicine
• Explores burgeoning global topics such as the implications of the USA’s withdrawal from the WHO and the emergence of China as a center for pharmaceutical research, development and patenting

Providing an accessible overview of the complex field of pharmaceutical regulation, this book is a necessary resource for scholars and students of health and biotechnology law. It is also beneficial for practitioners and policymakers in intellectual property law and pharmaceutical law.

Frederick M. Abbott, Edward Ball Eminent Scholar Professor of International Law, Florida State University College of Law, USA